Intellia Therapeutics Q3 EPS $(0.91) Misses $(0.80) Estimate, Sales $7.163M Miss $10.461M Estimate
Benzinga Newsdesk 12 hours ago
NewsEarningsEarnings Misses
Intellia Therapeutics (NASDAQ:NTLA) reported quarterly losses of $(0.91) per share which missed the analyst consensus estimate of $(0.80) by 15.19 percent. This is a 1.09 percent increase over losses of $(0.92) per
Intellia Therapeutics (NASDAQ:NTLA) reported quarterly losses of $(0.91) per share which missed the analyst consensus estimate of $(0.80) by 15.19 percent. This is a 1.09 percent increase over losses of $(0.92) per share from the same period last year. The company reported quarterly sales of $7.163 million which missed the analyst consensus estimate of $10.461 million by 31.53 percent. This is a 48.03 percent decrease over sales of $13.782 million the same period last year.